Brand Name: Lantus Solostar
Lantus Solostar is a medicine containing the active ingredient(s) insulin glargine. On this page you will find out more about Lantus Solostar, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS) You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance. Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions. Continue reading >>
Insulin
Indication BASAGLAR is a long-acting insulin used to control high blood sugar in adults and children with type 1 diabetes and adults with type 2 diabetes. Limitation of Use BASAGLAR is not for treating diabetic ketoacidosis. Important Safety Information Do not take BASAGLAR during episodes of low blood sugar or if you are allergic to insulin glargine or any of the ingredients in BASAGLAR. Do NOT reuse needles or share insulin pens, even if the needle has been changed. Before starting BASAGLAR, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to become pregnant, or if you are breastfeeding or planning to breastfeed. BASAGLAR should be taken once a day at the same time every day. Test your blood sugar levels while using insulin. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision. The most common side effect of insulin, including BASAGLAR, is low blood sugar (hypoglycemia), which may be serious and life threatening. Signs and symptoms may include dizziness or light-headedness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood change, or hunger. Do NOT dilute or mix BASAGLAR with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. BASAGLAR must only be used if the solution is clear and colorless with no particles visible. Always make sure you have the correct insulin before each injection. BASAGLAR may cause serious side effects that can lead to death, such as severe allergic reactions. Get emergency help if you have: Heart fa Continue reading >>
Math Calculations With Lantus Insulin
www.TakeRx.com Calculate the total quantity and the total days supply for the following Rx: Lantus 100U/ML 25 units sq qam (1 month supply) ------------------------------------------------------------ The days supply is 30 days as stated by the doctor. The sig says: inject 25 units subcutaneously every morning Now, we need to convert 25 units (U) into mL The insulin ratio is 100 units per 1 mL, that is, 1 mL per 100 units x / 25 U = 1 mL / 100 U x = (25 * 1) / 100 x = 0.25 mL So, the patient will inject 0.25 mL per day. Then, the quantity will be 0.25mL * 30 days which is 7.5mL But, the pharmacist will have to dispense a 10mL vial of Lantus insulin. In other words, one bottle of Lantus insulin has 10mL So, the total quantity to be dispensed is 10 mL Calculate the total quantity and the total days supply for the following Rx: Lantus insulin 30U sq am 20 days ------------------------------------------------------------ The doctor has prescribed Lantus 100U/mL insulin injection. The total days supply is 20 days as stated by the doctor. The sig says: inject 30 units subcutaneously in the morning Now, we need to convert 30 units into mL The insulin ratio is 100 units per 1 mL, that is, 1 mL per 100 units x / 30 U = 1 mL / 100 U x = (30 * 1) / 100 x = 0.3 mL The patient will inject 0.3 mL per day. Then, the total quantity will be 0.3 mL * 20 days which is 6 mL But, one bottle of Lantus insulin has 10 mL and therefore the pharmacist will dispense a 10mL vial of Lantus insulin. So, the total quantity to be dispensed is 10 mL Calculate the total quantity and the total days supply for the following Rx: Lantus 100U/ML cartridge sig: 30 units qam ------------------------------------------------------------ The box has 5 cartridges and each cartridge has 3 mL of insulin. So, if 1 ca Continue reading >>
Helping Patients With Diabetes And Visual Or Manual Impairment (part 2): Medication Administration
Insulin injection Insulin administration can be especially difficult for patients with visual impairment. The labeling of some insulin products recommends against the use of insulin products by blind or visually impaired patients without proper assistance from sighted trained personnel. Along with thorough education and practice, injection administration aids (Tables 1-3) are available to help these patients inject insulin safely and accurately. Insulin pens should always be recommended, unless cost or personal preference is a factor, as they are associated with better accuracy and ease of use than the traditional vial-and-syringe method.4 The Novo-Nordisk FlexPen, Sanofi-Aventis Solostar pen, and Eli Lilly KwikPen all make an audible click as the patient dials each unit, which helps to ensure accurate measurement of the prescribed dose. These disposable pens may also be easier to handle than the reusable pens. For patients who administer both a basal and a prandial insulin dose, several strategies are available to distinguish between the two, for both the pen and the traditional vial-and-syringe method. Flex-Pens have color-coded labels, packaging, and cartridge holders, as well as tactile and color differences on the injection buttons to aid in distinguishing among the three insulin types the company manufactures. Solostar pens have different colors for the entire pen body — blue for Apidra and gray for Lantus — which has been shown to reduce errors in insulin identification.5 Solostar pens also include tactile differences to signify the two different types of insulin. Patients who use the traditional vial-and-syringe method can use some of the same strategies to distinguish between the vials (e.g., a rubber band around the long-acting insulin vial), or they can s Continue reading >>
Sanofi Lantus Solostar Pen Assembly Plant, Yizhuang, Beijing
Christopher Viehbacher, the CEO of Sanofi, announced the cartridge aseptic production line at the plant in May 2012. Image courtesy of Sanofi. The Beijing plant of Sanofi has a design capacity of 48 million Lantus SoloSTAR insulin pens each year. Image courtesy of Sanofi. Groundbreaking of Sanofi’s Lantus SoloSTAR assembly and packaging plant in Beijing. Image courtesy of Sanofi. Sanofi China opened a new assembling and packaging facility for prefilled insulin devices in Beijing, China, in May 2012. The facility will produce the SoloSTAR insulin injection pens prefilled with Lantus, the company’s insulin drug. Sanofi China looks after the Chinese operations of the globally diversified healthcare company Sanofi. The plant will help Sanofi serve diabetics in China and other Asian countries. During the plant’s inauguration ceremony in May 2012, the company announced the addition of an aseptic production line for cartridges at the plant. Sanofi’s Chinese manufacturing sites and production Sanofi built the new plant in Beijing in its attempt to increase production base in China. The company operates six manufacturing sites in China, including one plant each in Beijing, Shenzhen, Tangshan and Nanchang, and two plants in Hangzhou. The Beijing plant was announced three years ago, in 2009. In April 2009 Sanofi signed an agreement with Beijing e-Town International Investment to set up a plant within the Beijing Economic-Technological Development Area (BDA). Phased construction of the pen assembling facility The Beijing manufacturing facility is a $90m project for Sanofi. It is being built in two phases. The assembly and packaging plant formed the first phase of the project. The second phase will involve addition of the cartridge aseptic production line. Transport infrastr Continue reading >>
Insulin Pen
Two types of modern, pre-filled insulin syringes. An insulin pen is used to inject insulin for the treatment of diabetes. Insulin is a hormone produced by the pancreas. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose. It was introduced and marketed as NovoPen by the Danish company Novo Nordisk in 1985. Types of pens[edit] A number of companies make insulin pens including Novo Nordisk, Aventis, Eli Lilly and Biocon. These companies produce pens for most of their insulins, including NovoLog/NovoRapid, Humalog, Levemir and Lantus. There are two pen systems: durable and prefilled: A durable pen uses a replaceable insulin cartridge. When the insulin cartridge is empty, the empty cartridge is disposed of and a new one is inserted in the pen. A prefilled pen is entirely disposable. The pen comes pre-filled with insulin, and when the insulin cartridge or reservoir is empty, the entire unit is discarded. Most brands of insulin are now available for use in pens, these include: NovoMix, NovoRapid and Levemir by Novo Nordisk Lantus and Apidra by Sanofi-Aventis Humulin and Humalog by Eli Lilly and Company INSUGEN and BASALOG by Biocon Global Patient Uptake[edit] Insulin pens are used by 95% of insulin-treated patients in Europe, Asia, Australia and Scandinavia with excellent results.[1] They are currently underutilized but growing in use in the United States. Insulin pens offer several significant advantages over insulin syringes: ease of handling, accuracy, and they are more discreet to use and easier to transport. To use an insulin pen[edit] How to prime an insulin pen. Screw or click on a new pen needle. If necessary, prime the pen to remove any air from the needle Continue reading >>
Lantus
Prescription Drugs Search or browse for information on Prescription Drugs Brand Name Lantus Common Name insulin glargine In this drug factsheet: DIN (Drug Identification Number) How does this medication work? What will it do for me? Insulin is a naturally occurring hormone made by the pancreas that helps our body use or store the glucose (sugar) it gets from food. For people with diabetes, either the pancreas does not make enough insulin to meet the body's requirements, or the body cannot properly use the insulin that is made. As a result, glucose cannot be used or stored properly and accumulates in the bloodstream. Insulin injected under the skin helps to lower blood glucose levels. There are many different types of insulin and they are absorbed at different rates and work for varying periods of time. Insulin glargine is an extended, long-acting insulin. It takes about 90 minutes to begin working after injection, and it stops working after about 24 hours. After injection, insulin glargine is released slowly and constantly into the bloodstream. This medication may be available under multiple brand names and/or in several different forms. Any specific brand name of this medication may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of this medication may not be used for all of the conditions discussed here. Your doctor may have suggested this medication for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are being given this medication, speak to your doctor. Do not stop using this medication without consulting your doctor. Do not give this medication to anyone else, even if they have the same symptoms as you do. It Continue reading >>
Insulin Glargine (rdna Origin) Injection
Insulin glargine is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood) who need insulin to control their diabetes. In people with type 1 diabetes, insulin glargine must be used with another type of insulin (a short-acting insulin). In people with type 2 diabetes, insulin glargine also may be used with another type of insulin or with oral medication(s) for diabetes. Insulin glargine is a long-acting, manmade version of human insulin. Insulin glargine works by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is used for energy. It also stops the liver from producing more sugar. Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Using medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes. Insulin glargine comes as a solution (liquid) to inject subcutaneously (under the Continue reading >>
Ready-to-use Cartridge Components May Help Insulin Manufacturers
The market for prefillable syringe systems (PFS) is growing at a rate of approximately 10 percent per year, with cartridge-based systems growing even faster at rates of 13 percent (2013 market outlook, IMS). The predominant areas of growth are within the insulin and biologics therapeutic areas, as well as overall growth within emerging markets. As patient needs evolve based on convenience, ease of use and home delivery of injectable drug products, prefilled drug delivery solutions, including injection systems based on prefilled cartridges will continue to grow. New device technology for self-injection will allow for safe administration, flexible dosing and, potentially, better patient compliance. An example of a common drug product delivered in cartridge form is the insulin product Lantus®, which uses the SoloSTAR® pen device. Lantus SoloSTAR demonstrates the benefit of cartridge delivery paired with a device by leveraging the “dial a dose” feature and ease of use offered by a pen injector as well as the small thin needles required for injection. Lantus SoloSTAR also provides more dosing units per prescription compared to single dose vial and syringe delivery which provides patients with more medication for the same co-pay. For pharmaceutical manufacturers, new fill-finish technology allows for a flexible design to fit multiple container systems (vial, PFS, cartridge). However, component processing is a source of risk for cartridge components, just as it is for syringe or vial components. To help simplify drug development and streamline manufacturing, pharmaceutical manufacturers should select cartridge plungers and lined seals in ready-to-use formats. West’s industry proven Westar® component processing reduces the risk of variability and the potential effects Continue reading >>
What Is The Most Important Information I Should Know About Insulin Glargine (lantus, Lantus Opticlik Cartridge, Lantus Solostar Pen)?
A A A Medications and Drugs Brand Names: Lantus, Lantus OptiClik Cartridge, Lantus Solostar Pen Generic Name: insulin glargine (Pronunciation: IN su lin AS part, IN su lin AS part PRO ta meen) What is the most important information I should know about insulin glargine (Lantus, Lantus OptiClik Cartridge, Lantus Solostar Pen)? What should I discuss with my healthcare provider before using insulin glargine (Lantus, Lantus OptiClik Cartridge, Lantus Solostar Pen)? What is insulin glargine (Lantus, Lantus OptiClik Cartridge, Lantus Solostar Pen)? Insulin glargine is a man-made form of a hormone that is produced in the body. It works by lowering levels of glucose (sugar) in the blood. Insulin glargine is a long-acting form of insulin that is slightly different from other forms of insulin that are not man-made. Insulin glargine is used to treat type 1 or type 2 diabetes. Insulin glargine may also be used for purposes not listed in this medication guide. What are the possible side effects of insulin glargine (Lantus, Lantus OptiClik Cartridge, Lantus Solostar Pen)? Get emergency medical help if you have any of these signs of insulin allergy: itching skin rash over the entire body, wheezing, trouble breathing, fast heart rate, sweating, or feeling like you might pass out. Hypoglycemia, or low blood sugar, is the most common side effect of insulin glargine. Symptoms include headache, hunger, weakness, sweating, tremors, irritability, trouble concentrating, rapid breathing, fast heartbeat, fainting, or seizure (severe hypoglycemia can be fatal). Carry hard candy or glucose tablets with you in case you have low blood sugar. Tell your doctor if you have itching, swelling, redness, or thickening of the skin where you inject insulin glargine. This is not a complete list of side effect Continue reading >>
How You Can Get Your Lantus And Apidra Through The Sanofi Patient Connection Program Absolutely Free
As part of our series on Diabetes, we are discussing Sanfi Aventis medications available to the uninsured through the Sanofi Patient Connection Program. Qualifying applicants receive free 90 day supplies of their Sanofi Aventis medications delivered directly to their doctor’s office. This program offers assistance with Apidra Vials and SoloStar Pens and Lantus Vials and SoloStar Pens. The Sanofi Patient Connection Program is available to uninsured Americans whose gross household income falls below 250% of the Federal Poverty Level. There are some exceptions for patients who are in the Medicare Part D donut hole and some Medicare eligible patients who have been denied Low Income Subsidy and Medicaid assistance. This program requires new applicants to submit supporting documents, called Proof of Income, or POI for short, to verify that your household income is below 250% of the Federal Poverty Level. The Sanofi Patient Connection program will either tax documentation or current proof of household income such as paycheck stubs, Social Security Award Letters, Unemployment Statements and even bank statements. If you are submitting current proof of income, be sure that you turn in your most recent months’ worth so that the program can get a clear understanding of your financial situation. If your household currently has zero income, you will need to submit your tax documentation. If you did not file taxes, a 4506-T Verification of Non-Filing Form can be submitted to the IRS and the form they return to you submitted to the PAP. For More information about what to send in as Proof Of Income, click here. If your tax documents show that your household income was over 250% of the Federal Poverty Level, but there has been a change and your current gross household income is below Continue reading >>
Get To Know The Lantus® Solostar® Pen
Do not take Lantus® during episodes of low blood sugar or if you are allergic to insulin or any of the inactive ingredients in Lantus®. Do not share needles, insulin pens, or syringes with others. Do NOT reuse needles. Before starting Lantus®, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to become pregnant or if you are breast-feeding or planning to breast-feed. Heart failure can occur if you are taking insulin together with certain medicines called TZDs (thiazolidinediones), even if you have never had heart failure or other heart problems. If you already have heart failure, it may get worse while you take TZDs with Lantus®. Your treatment with TZDs and Lantus® may need to be changed or stopped by your doctor if you have new or worsening heart failure. Tell your doctor if you have any new or worsening symptoms of heart failure, including: Sudden weight gain Tell your doctor about all the medications you take, including OTC medicines, vitamins, and supplements, including herbal supplements. Lantus® should be taken once a day at the same time every day. Test your blood sugar levels while using insulin, such as Lantus®. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision. Do NOT dilute or mix Lantus® with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Lantus® must only be used if the solution is clear and colorless with no particles visible. Always make sure you have the correct insulin before each injection. While using Lantus®, do not drive or operate heavy machinery until Continue reading >>
Lantus 100 Units/ml Solution For Injection In A Cartridge
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged. Below is a text only representation of the Patient Information Leaflet, the original can be viewed in PDF format using the link above. The text only version may be available from RNIB in large print, Braille or audio CD. For further information call RNIB Medicine Leaflet Line on 0800 198 5000. The product code(s) for this leaflet are: EU/1/00/134/005, EU/1/00/134/006, EU/1/00/134/013, EU/1/00/134/016, EU/1/00/134/017, EU/1/00/134/015, EU/1/00/134/014, EU/1/00/134/007. Lantus 100 units/ml solution for injection in a cartridge Package leaflet: Information for the user Lantus® 100 units/ml solution for injection in a cartridge insulin glargine Read all of this leaflet carefully before you start using this medicine because it contains important information for you. The instructions for using the insulin pen are provided with your insulin pen. Refer to them before using your medicine. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, pharmacist or nurse. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. 1. What Lantus is and what it is used for Lantus contains insulin glargine. This is a modified insulin, very similar to human insulin. Lantus is used to treat diab Continue reading >>
Lantus (insulin Glargine) Side Effects
What Is Lantus (Insulin Glargine)? Lantus is the brand name of insulin glargine, a long-acting insulin used to treat adults and children with type 1 diabetes mellitus and adults with type 2 diabetes mellitus to control high blood sugar. Lantus replaces the insulin that your body no longer produces. Insulin is a natural substance that allows your body to convert dietary sugar into energy and helps store energy for later use. In type 2 diabetes mellitus, your body does not produce enough insulin, or the insulin produced is not used properly, causing a rise in blood sugar. Like other types of insulin, Lantus is used to normalize blood sugar levels. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual dysfunction. Proper control of diabetes has also been shown to reduce your risk of a heart attack or stroke. Lantus is meant to be used alongside a proper diet and exercise program recommended by your doctor. Lantus is manufactured by Sanofi-Aventis. It was approved for use by the Food and Drug Administration (FDA) in 2000 as the first long-acting human insulin administered once a day with a 24-hour sugar-lowering effect. Lantus Warnings You will be taught how to properly inject this medication since that is the only way to use it. Do not inject cold insulin because this can be painful. Always wash your hands before measuring and injecting insulin. Lantus is always clear and colorless; look for cloudy solution or clumps in the container before injecting it. Do not use Lantus to treat diabetic ketoacidosis. A short-acting insulin is used to treat this condition. It is recommended that you take a diabetes education program to learn more about diabetes and how to manage it. Other medical problems may affect the use of this Continue reading >>
Pen Devices For Insulin Administration
GENERAL INFORMATION: What is an insulin pen? An insulin pen is a device used to inject insulin. The pen contains a cartridge of insulin and a needle. The pen may be reusable or disposable. You may need a different pen for each type of insulin you use. How do I get the insulin ready to use? Wash your hands before and after you use an insulin pen. Check the label and appearance of the insulin: Check that you are injecting the right type of insulin. Check the expiration date. Use a new insulin cartridge or disposable pen if the expiration date has passed. Check that the insulin is clear, colorless, and free of particles or clumps. Use a new insulin cartridge or disposable pen if the insulin does not look right. Follow the pen manufacturer's instructions for inserting an insulin cartridge into a reusable pen. Mix cloudy insulin: Roll the pen gently in the palms of your hands 10 times. A small bead in the cartridge mixes the insulin. Tilt the pen back and forth straight up, then straight down 10 times to make sure the insulin is mixed well. After you roll and tilt the pen, the insulin should be evenly mixed. If the insulin does not appear to be evenly mixed, repeat the mixing process. Do not use the insulin if there are clumps in it after mixing. How do I get the pen ready to use? Attach the disposable needle to the pen: Remove the pen cap. Clean the rubber seal on the insulin cartridge with a sterile alcohol swab. Attach the disposable needle to the pen. Remove the outer needle cap and save it to use after your injection. Remove the inner needle cap and throw it away. Use a new needle every time you inject insulin. Prime the pen before each injection: This releases a small amount of insulin into the pen to help get rid of air bubbles that may be in the pen. Air bubbles can Continue reading >>
